References
1. Wang K, Harnden A, Perera R, Gill P, Thomson A, Mant D. Clinical
symptoms and signs for the diagnosis of Mycoplasma pneumoniae in
children and adolescents with community-acquired pneumonia. Cochrane
Database Syst Rev. 2012; 10:CD009175.
2. Jain S, Williams DJ, Arnold SR, Ampofo K, Rolfs R. Community-acquired
pneumonia requiring hospitalization among U.S. children. New England
Journal of Medicine. 2015; 372:835.
3. Chalker V, Stocki T, Litt D, Bermingham A, Watson J, Fleming D, et
al. Increased detection of Mycoplasma pneumoniae infection in children
in England and Wales, October 2011 to January 2012. Eurosurveillance:
bulletin europeen sur les maladies transmissibles = European
communicable disease bulletin. 2012; 17:5-9.
4. Nir-Paz R, Abutbul A, Moses AE, Block C, Hidalgo-Grass C. Ongoing
epidemic of Mycoplasma pneumoniae infection in Jerusalem, Israel, 2010
to 2012. Eurosurveillance: bulletin europeen sur les maladies
transmissibles = European communicable disease bulletin. 2012; 17.
5. Polkowska A, Harjunpää A, Toikkanen S, Lappalainen M, Vuento R,
Vuorinen T, et al. Increased incidence of Mycoplasma pneumoniae
infection in Finland, 2010-2011. Euro Surveill. 2012.
6. Rasmussen JN, Voldstedlund M, Andersen RL, Ellermanneriksen S, Jensen
TG, Johansen HK, et al. Increased incidence of Mycoplasma pneumoniae
infections detected by laboratory-based surveillance in Denmark in 2010.
Euro Surveill. 2010; 15:2-5.
7. Lu CY, Yen TY, Chang LY, Liau YJ, Liu HH, Huang LM. Multiple-locus
variable-number tandem-repeat analysis (MLVA) of macrolide-susceptible
and -resistant Mycoplasma pneumoniae in children in Taiwan. J Formos Med
Assoc. 2020; 119:1539-45.
8. Zhao F, Li J, Liu J, Guan X, Gong J, Liu L, et al. Antimicrobial
susceptibility and molecular characteristics of Mycoplasma pneumoniae
isolates across different regions of China. Antimicrob Resist Infect
Control. 2019; 8:143.
9. Dégrange S, Cazanave C, Charron A, Renaudin H, Bébéar C, Bébéar C.
Development of Multiple-Locus Variable-Number Tandem-Repeat Analysis for
Molecular Typing of Mycoplasma pneumoniae. Journal of Clinical
Microbiology. 2009; 47:914-23.
10. Dumke R, Jacobs E. Culture-independent multi-locus variable-number
tandem-repeat analysis (MLVA) of Mycoplasma pneumoniae. Journal of
Microbiological Methods. 2011; 86:393-6.
11. Alvaro J, Benitez, Maureen H, Diaz, Bernard J, Wolff, et al.
Multilocus variable-number tandem-repeat analysis of Mycoplasma
pneumoniae clinical isolates from 1962 to the present: a retrospective
study. Journal of clinical microbiology. 2012.
12. Sun H, Xue G, Yan C, Li S, Ling C, Yi Y, et al. Multiple-Locus
Variable-Number Tandem-Repeat Analysis of Mycoplasma pneumoniae Clinical
Specimens and Proposal for Amendment of MLVA Nomenclature. Plos One.
2013; 8:e64607.
13. Yan C, Sun H, Xue G, Zhao H, Wang L, Feng Y, et al. A single-tube
multiple-locus variable-number tandem-repeat analysis of Mycoplasma
pneumoniae clinical specimens by use of multiplex PCR-capillary
electrophoresis. J Clin Microbiol. 2014; 52:4168-71.
14. Diaz MH, Benitez AJ, Cross KE, Hicks LA, Kutty P, Bramley AM, et al.
Molecular Detection and Characterization of Mycoplasma pneumoniae Among
Patients Hospitalized With Community-Acquired Pneumonia in the United
States. Open Forum Infect Dis. 2015; 2:ofv106.
15. Dumke R, Schnee C, Pletz MW, Rupp J, Jacobs E, Sachse K, et al.
Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired
pneumonia, Germany, 2011-2012. Emerg Infect Dis. 2015; 21:426-34.
16. Sun H, Xue G, Yan C, Li S, Cao L, Yuan Y, et al. Multiple-locus
variable-number tandem-repeat analysis of mycoplasma pneumoniae clinical
specimens and proposal for amendment of MLVA nomenclature. PLoS One.
2013; 8:e64607.
17. Xue G, Li M, Wang N, Zhao J, Wang B, Ren Z, et al. Comparison of the
molecular characteristics of Mycoplasma pneumoniae from children across
different regions of China. PLoS One. 2018; 13:e0198557.
18. Xue G, Li M, Wang N, Zhao J, Bei W, Ren Z, et al. Comparison of the
molecular characteristics of Mycoplasma pneumoniae from children across
different regions of China. PLoS ONE. 2018; 13:e0198557.
19. Yu S, Seto J, Shimotai Y. Multiple-Locus Variable-Number
Tandem-Repeat Analysis of Mycoplasma pneumoniae Isolates between 2004
and 2014 in Yamagata, Japan: Change of Molecular Characteristics during
an 11-year Period. Japanese Journal of Infectious Diseases. 2017; 70.
20. Pak-Leung, Ho, Pierra, Law, Betsy, Chan, et al. Emergence of
Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to
Increasing Macrolide Resistance in Multilocus Variable-Number
Tandem-Repeat Analysis Type 4-5-7-2. Journal of Clinical Microbiology.
2015.
21. Dumke R, Schnee C, Pletz MW, Rupp J, Jacobs E, Sachse K, et al.
Mycoplasma pneumoniae and Chlamydia spp. Infection in Community-Acquired
Pneumonia, Germany, 2011–2012. Emerging Infectious Diseases. 2015;
21:426-34.
22. Diaz MH, Benitez AJ, Cross KE, Hicks LA, Kutty P, Bramley AM, et al.
Molecular Detection and Characterization of Mycoplasma pneumoniae Among
Patients Hospitalized With Community-Acquired Pneumonia in the United
States. Oxford University Press. 2015.
23. Whistler, Toni, Sawatwong, Pongpun, Diaz, Maureen H, et al.
Molecular Characterization of Mycoplasma pneumoniae Infections in Two
Rural Populations of Thailand from 2009 to 2012.
24. Xue G, Wang Q, Yan C, Jeoffreys N, Wang L, Li S, et al. Molecular
Characterizations of PCR-Positive Mycoplasma pneumoniae Specimens
Collected from Australia and China. Journal of Clinical Microbiology.
2014; 52.
25. Dumke R, Stolz S, Jacobs E, Juretzek T. Molecular characterization
of macrolide resistance of a Mycoplasma pneumoniae strain that developed
during therapy of a patient with pneumonia. International Journal of
Infectious Diseases. 2014; 29:197-9.
26. Tsutomu I, Yu S, Junji S, Chieko A, Katsumi M, Yoko M. Two cases of
macrolide resistance in Mycoplasma pneumoniae acquired during the
treatment period. Journal of Antimicrobial Chemotherapy. 2013:724-5.
27. Cardinale F, Chironna M, Dumke R, Binetti A, aleno CD, Sallustio A,
et al. Macrolide-resistant Mycoplasma pneumoniae in paediatric
pneumonia. European Respiratory Journal. 2011; 37:1522-4.
28. Yang TI, Chang T, Lu CY, Chen JM, Lee PI, Huang LM, et al.
Mycoplasma pneumoniae in pediatric patients: Do macrolide-resistance
and/or delayed treatment matter? Journal of microbiology, immunology,
and infection = Wei mian yu gan ran za zhi. 2018; 52.